title: T-Cell Therapy Has Lasting Effects.
abstract: The CAR T-cell therapy CTL019 produces long-term remissions in acute lymphocytic leukemia and non-Hodgkin lymphomas, according to research presented at the annual meeting of the American Society of Hematology.
mesh_terms: D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000401:mortality / Q000628:therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000401:mortality / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism; D016019:Survival Analysis; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D016896:Treatment Outcome
chemical_list: C000598123:CTL019 chimeric antigen receptor; D011948:Receptors, Antigen, T-Cell